Research.Patient.info
Enteropathy-Associated T-Cell Lymphoma research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A safety study of PF-08046045/SGN-35T in adults with advanced cancers
This study is looking at a new medicine for people with certain advanced cancers, including different types of lymphoma. It's the first time this medicine is being given to people, to check if it's safe and how it works in the body.
Germany · Spain · Denmark - active not recruitingPHASE2
A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)
This study is testing a new combination of treatments, pembrolizumab (an immunotherapy drug) and radiotherapy, for people with specific types of advanced skin lymphoma (CTCL, Mycosis Fungoides, or Sezary Syndrome) that have returned or not responded to previous treatments.
United Kingdom